Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia
Clinical trial NCT02602314 · UNKNOWN
Trial details
- NCT number
- NCT02602314
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-11
- Primary completion
- 2023-02-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.